Skip to main content
The BMJ logoLink to The BMJ
. 2003 Feb 15;326(7385):382–384. doi: 10.1136/bmj.326.7385.382

Fatal dysnatraemia caused by elective colonoscopy

J Carlos Ayus a, Robert Levine b, Allen I Arieff c
PMCID: PMC1125242  PMID: 12586675

Recent data suggest that colonoscopy is superior to other screening procedures for the detection of colorectal cancer in people aged over 50.1 The American College of Gastroenterology has recently recommended that individuals over 50 at average risk of colon cancer should have elective colonoscopy every 10 years, and those at higher risk more frequently.2 In the United States, 239 000 inpatient colonoscopies were performed in 1995,3 and this figure rose by 20% to 286 000 by 1999.4 Yet complications of elective colonoscopy are reported to be infrequent: colon perforation or bleeding occurs in fewer than 1% of cases, and electrolyte disorders are not even mentioned.1,58

Preparation of the colon for colonoscopy involves a thorough cleansing of the large bowel by one of several different methods, in some of which large volumes of a liquid cleansing agent may be given: one method involves drinking 4 l polyethylene glycol solution; another involves taking 90 ml sodium phosphate solution.5,9 Both methods can lead to diarrhoea with nausea, vomiting, and potential dehydration,9 often resulting in raised plasma concentrations of antidiuretic hormone.10 Thus electrolyte imbalance may occur, either from increased oral water intake with abnormal fluid retention or from increased fluid losses into the gastrointestinal tract.

Furthermore, preparation for colonoscopy causes substantial release of antidiuretic hormone,10 and gastrointestinal fluid losses may cause excessive thirst, so increasing fluid intake. In patients with impaired ability to excrete water, the raised plasma antidiuretic hormone concentrations can lead to hyponatraemia; if thirst is impaired, excessive fluid losses can lead to hypernatraemia. In elderly patients in hospital, acute hypernatraemia and hyponatraemia may be fatal,11,12 yet there are no reports of fatal electrolyte complications associated with elective colonoscopy. We recently saw three patients who developed symptoms of hypernatraemia or hyponatraemia (dysnatraemia) as a complication of elective colonoscopy.

Case reports

Over a period of 28 months (December 1998 to March 2001), JAC and AIA advised elective colonoscopy for three patients: one for unexplained weight loss, one for bleeding, and one as routine screening. Their ages ranged from 51 to 73; two were men and one was a woman. All three patients developed symptoms of dysnatraemia, and the laboratory findings at the time this was noted are shown in the table. All three patients had been given 4 l of a standard bowel preparation solution containing an isosmotic solution of polyethylene glycol and balanced electrolytes (Golytely; Braintree Laboratories, Braintree, MA) to prepare the bowel.9,13 Plasma sodium was measured at the time patients first showed symptoms of dysnatraemia.

In patients 1 and 2, taking the cleansing solution induced nausea, abdominal distension, and diarrhoea, and both patients reported then drinking substantially increased amounts of fluids. Patient 1 was concomitantly taking thiazides. Before preparation, her plasma sodium concentration was 138 mmol/l. After drinking all 4 l of the preparation solution, she continued to drink water and reported nausea, vomiting, and headache. The following morning she was found unconscious in bed; she had several tonic-clonic seizures on the way to hospital in the ambulance; and in hospital she developed status epilepticus. On admission her plasma sodium concentration was 116 mmol/l. She was immediately intubated and mechanically ventilated and treated with intravenous hypertonic sodium chloride solution (table). She recovered fully and was discharged from the hospital. Two months later she had no neurological abnormalities, and a magnetic resonance scan of the brain was normal.

Patient 2 had end stage renal failure and was receiving regular haemodialysis. Before colonoscopy his plasma sodium concentration was normal (table). After taking the cleansing solution, he had nausea and vomiting with diarrhoea, and he increased his oral water intake. After the colonoscopy was completed, he developed grand mal seizures followed by fatal cardiopulmonary arrest. Measurement of his electrolytes showed hyponatraemia.

Patient 3 was also in end stage renal failure, receiving regular haemodialysis; he also had diabetes. He developed massive diarrhoea after taking the preparatory solution, with fluid losses up to 3.5 l/day; in addition, he vomited as much as 4 l of fluid a day. The massive vomiting suggested gastric obstruction, but endoscopy showed the gastric outlet was patent. This patient did not have increased fluid intake after taking the preparation. He underwent colonoscopy, and electrolytes measured after colonoscopy showed development of hypernatraemia with metabolic alkalosis (table). He developed shock and clouding of consciousness, and then respiratory arrest.

An additional male patient, not detailed here because permission to do so could not be obtained, had a similar clinical course to that of patient 3, with massive diarrhoea and vomiting which progressed to hypernatraemia, followed by seizures, aspiration, and fatal cardiopulmonary arrest.

Discussion

The present study shows that preparation for elective colonoscopy can cause fatal acute overt dysnatraemia. The electrolyte abnormalities we observed resulted from ingestion of large volumes of bowel preparation solution in patients prone to developing alterations of water handling. Oral ingestion of the isotonic cleansing solution does not by itself affect the plasma sodium concentration,9,13 but in patients with potentially impaired renal handling of water,14 or in elderly patients who have decreased thirst,15 there is an increased risk of dysnatraemia. The cleansing solution tends to induce nausea and vomiting, which are strong stimuli for increased secretion.10 The ensuing reduction in plasma volume and consequent rise in plasma antidiuretic hormone concentration can lead to increased thirst, with the potential for hyponatraemia,16 as occurred in patients 1 and 2, whose ability to excrete water was impaired by taking diuretics and by pre-existing renal failure. By contrast, patient 3 had decreased fluid intake at the time when he was losing substantial amounts of water from the upper and lower gastrointestinal tract, and as a result he developed severe hypernatraemia.

In the two patients who died, dysnatraemia was not suspected before the actual colonoscopy and was most probably present at that time. Most patients routinely receive sedation during the procedure, which in the case of a patient with dysnatraemia can temporarily mask any symptoms, with fatal consequences.

Chronic renal failure presents special problems with respect to water handling. Uraemic patients are frequently subject to gastroparesis, as well as colonic bleeding.17 The presence of uraemic and diabetic gastritis in patient 3 may have played a role in the massive upper gastrointestinal loss of fluid after colonoscopy.

This report does not deal with the incidence of dysnatraemia associated with elective colonoscopy. Under the current recommendation that colonoscopy be done routinely every 10 years from age 50 onwards, many elderly people will be candidates for this procedure and therefore at risk of dysnatraemia. Patients with impaired ability to excrete free water include those with renal insufficiency, hypothyroidism, mineralocorticoid deficiency, liver cirrhosis, or heart failure, as well as those taking drugs which impair free excretion of water, including thiazide diuretics, non-steroidal anti-inflammatory drugs, and angiotensin converting enzyme inhibitors.16 Such individuals will require increased surveillance, which should include routine measurement of plasma sodium after colonoscopy.

Table.

Laboratory values and clinical findings for patients with dysnatraemia as a complication of elective colonoscopy

Characteristic or finding
Patient 1
Patient 2
Patient 3
Age 62 51 73
Sex F M M
Illness Hypertension, hyperlipidaemia Diabetes, end stage renal disease Diabetes, end stage renal disease
Prescription drugs Thiazide Amlodipine, atenolol, Lasix, Phoslo, Prilosec Prozac, atenolol, tegretol, Prevacid, ramipril, Prandin
Sodium (mmol/l):
 24 hours before colonoscopy preparation 138 138 134
 After colonoscopy preparation 116 134 Not done
 After colonoscopy Not done 122 156

Potassium (mmol/l) 3.9 5.1 3.2

Chloride (mmol/l) 79 94 82

Bicarbonate (mmol/l) 26 20 55

Urea (mmol/l) 2.5 24.3 15

Creatinine (mg/dl) 0.6 7.7 5.9

Glucose (mmol/l) Not done 5.3 11.3
Blood pressure (mm Hg) 130/90 167/78 75/45

Temperature (°C) 36.7 38.1 36.1

Heart rate (beats/min) 90 103 152

Clinical presentation Seizures Emesis, idioventricular rhythm, cardiopulmonary arrest Obtundation, shock

Computed tomograpy or magnetic resonance imaging of brain Cerebral oedema, no neoplasm or bleeding Not done Not done
Treatment for dysnatraemia Plasma sodium increased with 3% NaCl from 116 to 130 mmol/l in 24 hours None Plasma sodium decreased from 156 to 140 mmol/l with 0.45% NaCl in 24 hours
Outcome Complete recovery Died Died

Colonoscopy can cause fatal dysnatraemia, and plasma sodium should always be checked after the procedure

Footnotes

Funding: None.

Competing interests: None declared.

References

  • 1.Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555–560. doi: 10.1056/NEJMoa010328. [DOI] [PubMed] [Google Scholar]
  • 2.Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868–877. doi: 10.1111/j.1572-0241.2000.02059.x. [DOI] [PubMed] [Google Scholar]
  • 3.National Health Survey N; Department of Health and Human Services., editors Vital and health statistics: detailed diagnoses and procedures, national hospital discharge survey, 1995. Hyattsville, MD: National Center for Health Statistics; 1997. Number of all listed procedures for inpatients discharged from short-stay non-federal hospitals; p. 125. [Google Scholar]
  • 4.National Health Survey N; Department of Health and Human Services, editors. Vital and health statistics: detailed diagnoses and procedures, national hospital discharge survey 1999. Hyattsville, MD: National Center for Health Statistics; 1999. Number of all listed procedures for inpatients discharged from short-stay non-federal hospitals; p. 172. [Google Scholar]
  • 5.Detsky AS. Screening for colon cancer—can we afford colonoscopy? N Engl J Med. 2001;345:607–608. doi: 10.1056/NEJM200108233450809. [DOI] [PubMed] [Google Scholar]
  • 6.Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;343:162–168. doi: 10.1056/NEJM200007203430301. [DOI] [PubMed] [Google Scholar]
  • 7.Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607. doi: 10.1056/NEJM200011303432203. [DOI] [PubMed] [Google Scholar]
  • 8.Waye JD, Lewis BS, Yessayan S. Colonoscopy: a prospective report of complications. J Clin Gastrenterol. 1992;15:347–351. [PubMed] [Google Scholar]
  • 9.Cohen SM, Wexner SD, Binderow SR, Nogueras JJ, Daniel N, Ehrenpreis ED, et al. Prospective, randomised, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum. 1994;37:689–696. doi: 10.1007/BF02054413. [DOI] [PubMed] [Google Scholar]
  • 10.Hampton KK, Grant PJ, Primrose J, Dean HG, Davies JA, Prentice CRM. Haemostatic responses and vasopressin release during colonoscopy in man. Clin Sci. 1991;81:257–260. doi: 10.1042/cs0810257. [DOI] [PubMed] [Google Scholar]
  • 11.Snyder NA, Feigal DW, Arieff AI. Hypernatraemia in elderly patients. A heterogeneous, morbid, and iatrogenic entity. Ann Intern Med. 1987;107:309–319. doi: 10.7326/0003-4819-107-2-309. [DOI] [PubMed] [Google Scholar]
  • 12.Ayus JC, Arieff AI. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA. 1999;281:2299–2304. doi: 10.1001/jama.281.24.2299. [DOI] [PubMed] [Google Scholar]
  • 13.Sifton DW, editor. Physicians desk reference. Montvale, NJ: Medical Economics Co; 2001. pp. 990–991. [Google Scholar]
  • 14.Ayus JC, Arieff AI. Pathogenesis and prevention of hyponatremic encephalopathy. Endocrinol Metabol Clin North Am. 1993;22:425–446. [PubMed] [Google Scholar]
  • 15.Phillips PA, Rolls BJ, Ledingham JGG, Forsling ML, Morton JJ, Crowe MJ, et al. Reduced thirst after water deprivation in healthy elderly men. N Engl J Med. 1984;311:753–759. doi: 10.1056/NEJM198409203111202. [DOI] [PubMed] [Google Scholar]
  • 16.Verbalis JG. The syndrome of inappropriate antidiuretic hormone secretion and other hypoosmolar disorders. In: Schrier RW, Gottschalk CW, editors. Diseases of the kidney. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 2511–2548. [Google Scholar]
  • 17.Nickl NJ. Gastrointestinal tract in uremia. In: Massry SG, Glassock RJ, editors. Massry and Glassock's textbook of nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 1330–1341. [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES